hepatitis B carrier
Jump to navigation
Jump to search
Laboratory
- hepatitis B virus DNA in serum: positive, but low titer (< 10,000 IU/mL)*
- serum ALT normal*
- serum HBsAg positive
- serum HBsAb negative
- serum HBcIgM negative
- serum HBcIgG positive
- serum HBeAg negative
- serum HBeAb variable
* useful for survelliance of inactive carrier (every 6-12 months)
Diagnostic procedures
- survelliance for hepatocellular carcinoma in high-risk (high hepatitis B virus DNA) with abdominal ultrasound every 6 months[1]*
* survelliance with serum alpha-fetoprotein insufficient[1]
Management
- no treatment required[1]
More general terms
Additional terms
References
- ↑ Jump up to: 1.0 1.1 1.2 1.3 Medical Knowledge Self Assessment Program (MKSAP) 16, 17, 18 American College of Physicians, Philadelphia 2012, 2015, 2018
- ↑ NEJM Knowledge+ Question of the Week. Dec 10, 2019 https://knowledgeplus.nejm.org/question-of-week/506/
- ↑ Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology 2009 Aug 29; 50:661 PMID: https://www.ncbi.nlm.nih.gov/pubmed/19714720 Free full text
- ↑ European Association for the Study of the Liver. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol 2017 Aug; 67:370 PMID: https://www.ncbi.nlm.nih.gov/pubmed/28427875